COMBINED ORAL CONTRACEPTIVE (ETHINYLESTRADIOL/ LEVONORGESTREL) ALLEVIATES LIPID AND LACTATE ALTERATIONS IN PLASMODIUM BERGHEI-INFECTED MICE
Abdulkareem, A., Babamale, A., Abe, E., Olatunji, L., Ugbomoiko, U. (2022). COMBINED ORAL CONTRACEPTIVE (ETHINYLESTRADIOL/ LEVONORGESTREL) ALLEVIATES LIPID AND LACTATE ALTERATIONS IN PLASMODIUM BERGHEI-INFECTED MICE. EKB Journal Management System, 45(2), 925-934. doi: 10.21608/bfsa.2022.271773
Adam Olaitan Abdulkareem; Abdulkareem Olarewaju Babamale; Emmanuel Olusegun Abe; Lawrence Aderemi Olatunji; Uade Samuel Ugbomoiko. "COMBINED ORAL CONTRACEPTIVE (ETHINYLESTRADIOL/ LEVONORGESTREL) ALLEVIATES LIPID AND LACTATE ALTERATIONS IN PLASMODIUM BERGHEI-INFECTED MICE". EKB Journal Management System, 45, 2, 2022, 925-934. doi: 10.21608/bfsa.2022.271773
Abdulkareem, A., Babamale, A., Abe, E., Olatunji, L., Ugbomoiko, U. (2022). 'COMBINED ORAL CONTRACEPTIVE (ETHINYLESTRADIOL/ LEVONORGESTREL) ALLEVIATES LIPID AND LACTATE ALTERATIONS IN PLASMODIUM BERGHEI-INFECTED MICE', EKB Journal Management System, 45(2), pp. 925-934. doi: 10.21608/bfsa.2022.271773
Abdulkareem, A., Babamale, A., Abe, E., Olatunji, L., Ugbomoiko, U. COMBINED ORAL CONTRACEPTIVE (ETHINYLESTRADIOL/ LEVONORGESTREL) ALLEVIATES LIPID AND LACTATE ALTERATIONS IN PLASMODIUM BERGHEI-INFECTED MICE. EKB Journal Management System, 2022; 45(2): 925-934. doi: 10.21608/bfsa.2022.271773